Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Lucy J. Campbell, Mitesh Desai, Aseel Hegazi, Fowzia Ibrahim, Narbeh Melikian, Phillip Hay, Julie M. Fox & Frank A. Post. (2012) Renal Impairment Is Associated With Coronary Heart Disease in HIV-Positive Men. HIV Clinical Trials 13:6, pages 343-349.
Read now
Read now
Articles from other publishers (38)
Sandra E. Safo, Lillian Haine, Jason Baker, Cavan Reilly, Daniel Duprez, James D. Neaton, Mamta K. Jain, Alejandro Arenas‐Pinto, Mark Polizzotto & Therese Staub. (2023) Derivation of a Protein Risk Score for Cardiovascular Disease Among a Multiracial and Multiethnic HIV+ Cohort. Journal of the American Heart Association 12:13.
Crossref
Crossref
. (2023) Long-Term Benefits from Early Antiretroviral Therapy Initiation in HIV Infection. NEJM Evidence 2:3.
Crossref
Crossref
Adi Noiman, Allahna Esber, Xun Wang, Emmanuel Bahemana, Yakubu Adamu, Michael Iroezindu, Francis Kiweewa, Jonah Maswai, John Owuoth, Lucas Maganga, Anuradha Ganesan, Ryan C. Maves, Tahaniyat Lalani, Rhonda E. Colombo, Jason F. Okulicz, Christina Polyak, Trevor A. Crowell, Julie A. Ake & Brian K. Agan. (2022) Clinical factors and outcomes associated with immune non-response among virally suppressed adults with HIV from Africa and the United States. Scientific Reports 12:1.
Crossref
Crossref
Michelle Floris-MooreAndrew EdmondsSonia NapravnikAdaora A. Adimora. (2020) Computerized Adjudication of Coronary Heart Disease Events Using the Electronic Medical Record in HIV Clinical Research: Possibilities and Challenges Ahead. AIDS Research and Human Retroviruses 36:4, pages 306-313.
Crossref
Crossref
Maria J Vivancos-Gallego, Hajra Okhai, Maria J Perez-Elías, Cristina Gomez-Ayerbe, Ana Moreno-Zamora, Jose L Casado, Carmen Quereda, Javier Martinez Sanz, Matilde Sanchez-Conde, Sergio Serrano-Villar, Santos Del Campo, Fernando Dronda, Juan Carlos Galan, Caroline A Sabin & Santiago Moreno. (2019)
CD4
+
:CD8
+
T-cell Ratio Changes in People with HIV Receiving Antiretroviral Treatment
. Antiviral Therapy 25:2, pages 91-100.
Crossref
Crossref
Nicole Wyman Engen, Kathy Huppler Hullsiek, Waldo H Belloso, Elizabeth Finley, Fleur Hudson, Eileen Denning, Catherine Carey, Mary Pearson & Jonathan Kagan. (2019) A randomized evaluation of on-site monitoring nested in a multinational randomized trial. Clinical Trials 17:1, pages 3-14.
Crossref
Crossref
Álvaro H Borges, Jacqueline Neuhaus, Shweta Sharma, James D Neaton, Keith Henry, Olga Anagnostou, Teresa Staub, Sean Emery & Jens D Lundgren. (2019) The Effect of Interrupted/Deferred Antiretroviral Therapy on Disease Risk: A SMART and START Combined Analysis. The Journal of Infectious Diseases 219:2, pages 254-263.
Crossref
Crossref
Krista J. Siefried, Stephen Kerr, Robyn Richardson, Limin Mao, John Rule, John McAllister, John de Wit & Andrew Carr. (2019) Socioeconomic and psychosocial factors are associated with poor treatment outcomes in Australian adults living with HIV: a case-control study. Sexual Health 16:6, pages 548.
Crossref
Crossref
Sosthene Tsongo Vululi, Samuel Bugeza, Muyinda Zeridah, Henry Ddungu, Akello Betty Openy, Mubiru Frank & Rosalind Parkes-Ratanshi. (2018) Prevalence of lower limb deep venous thrombosis among adult HIV positive patients attending an outpatient clinic at Mulago Hospital. AIDS Research and Therapy 15:1.
Crossref
Crossref
Jens D. Lundgren, Alvaro H. Borges & James D. Neaton. (2018) Serious Non-AIDS Conditions in HIV: Benefit of Early ART. Current HIV/AIDS Reports 15:2, pages 162-171.
Crossref
Crossref
Krista J. Siefried, Limin Mao, Lucette A. Cysique, John Rule, Michelle L. Giles, Don E. Smith, James McMahon, Tim R. Read, Catriona Ooi, Ban K. Tee, Mark Bloch, John de Wit & Andrew Carr. (2018) Concomitant medication polypharmacy, interactions and imperfect adherence are common in Australian adults on suppressive antiretroviral therapy. AIDS 32:1, pages 35-48.
Crossref
Crossref
James G Hakim, Jennifer Thompson, Cissy Kityo, Anne Hoppe, Andrew Kambugu, Joep J van Oosterhout, Abbas Lugemwa, Abraham Siika, Raymond Mwebaze, Aggrey Mweemba, George Abongomera, Margaret J Thomason, Philippa Easterbrook, Peter Mugyenyi, A Sarah Walker, Nicholas I Paton, E Agweng, P Awio, G Bakeinyaga, C Isabirye, U Kabuga, S Kasuswa, M Katuramu, F Kiweewa, H Kyomugisha, E Lutalo, D Mulima, H Musana, G Musitwa, V Musiime, M Ndigendawan, H Namata, J Nkalubo, P Ocitti Labejja, P Okello, P Olal, G Pimundu, P Segonga, F Ssali, Z Tamale, D Tumukunde, W Namala, R Byaruhanga, J Kayiwa, J Tukamushaba, S Abunyang, D Eram, O Denis, R Lwalanda, L Mugarura, J Namusanje, I Nankya, E Ndashimye, E Nabulime, D Mulima, O Senfuma, G Bihabwa, E Buluma, A Elbireer, D Kamya, M Katwere, R Kiggundu, C Komujuni, E Laker, E Lubwama, I Mambule, J Matovu, A Nakajubi, J Nakku, R Nalumenya, L Namuyimbwa, F Semitala, B Wandera, J Wanyama, H Mugerwa, E Ninsiima, T Ssenkindu, S Mwebe, L Atwine, H William, C Katemba, S Abunyang, M Acaku, P Ssebutinde, H Kitizo, J Kukundakwe, M Naluguza, K Ssegawa, Namayanja, F Nsibuka, P Tuhirirwe, M Fortunate, J Acen, J Achidri, A Amone, M Chamai, J Ditai, M Kemigisa, M Kiconco, C Matama, D Mbanza, F Nambaziira, M Owor Odoi, A Rweyora, G Tumwebaze, H Kalanzi, J Katabaazi, A Kiyingi, M Mbidde, M Mugenyi, P Okong, I Senoga, M Abwola, D Baliruno, J Bwomezi, A Kasede, M Mudoola, R Namisi, F Ssennono, S Tuhirwe, G Amone, J Abach, I Aciro, B Arach, P Kidega, J Omongin, E Ocung, W Odong, A Philliam, H Alima, B Ahimbisibwe, E Atuhaire, F Atukunda, G Bekusike, A Bulegyeya, D Kahatano, S Kamukama, J Kyoshabire, A Nassali, A Mbonye, T M Naturinda, Ndukukire, A Nshabohurira, H Ntawiha, A Rogers, M Tibyasa, S Kiirya, D Atwongyeire, A Nankya, C Draleku, D Nakiboneka, D Odoch, L Lakidi, R Ruganda, R Abiriga, M Mulindwa, F Balmoi, S Kafuma, E Moriku, A Reid, E Chidziva, G Musoro, C Warambwa, G Tinago, S Mutsai, M Phiri, S Mudzingwa, T Bafana, V Masore, C Moyo, R Nhema, S Chitongo, Robert Heyderman, Lucky Kabanga, Symon Kaunda, Aubrey Kudzala, Linly Lifa, Jane Mallewa, Mike Moore, Chrissie Mtali, George Musowa, Grace Mwimaniwa, Rosemary Sikwese, Milton Ziwoya, H Chimbaka B Chitete, S Kamanga, T Kayinga E Makwakwa, R Mbiya, M Mlenga, T Mphande, C Mtika, G Mushani, O Ndhlovu, M Ngonga, I Nkhana, R Nyirenda, P Cheruiyot, C Kwobah, W Lokitala Ekiru, M Mokaya, A Mudogo, A Nzioka, M Tanui, S Wachira, K Wools-Kaloustian, P Alipalli, E Chikatula, J Kipaila, I Kunda, S Lakhi, J Malama, W Mufwambi, L Mulenga, P Mwaba, E Mwamba, M Namfukwe, E Kerukadho, B Ngwatu, J Birungi, J Boles, A Burke, L Castle, S Ghuman, L Kendall, S Tebbs, J Whittle, H Wilkes, N Young, M Spyer, C Kapuya, F Kyomuhendo, D Kyakundi, N Mkandawire, S Mulambo, S Senyonjo, B Angus, A Arenas-Pinto, A Palfreeman, F Post, D Ishola, J Arribas, R Colebunders, M Floridia, M Giuliano, P Mallon, P Walsh, M De Rosa, E Rinaldi, I Weller, C Gilks, A Kangewende, S Lakhi, E Luyirika, F Miiro, S Ojoo, S Phiri, A Wapakabulo, T Peto, J Matenga, G Cloherty, J van Wyk, M Norton, S Lehrman, P Lamba, K Malik, J Rooney, W Snowden & J Villacian. (2018) Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trial. The Lancet Infectious Diseases 18:1, pages 47-57.
Crossref
Crossref
Krista J. Siefried, Limin Mao, Stephen Kerr, Lucette A. Cysique, Thomas M. Gates, John McAllister, Anthony Maynard, John de Wit & Andrew Carr. (2017) Socioeconomic factors explain suboptimal adherence to antiretroviral therapy among HIV-infected Australian adults with viral suppression. PLOS ONE 12:4, pages e0174613.
Crossref
Crossref
Nicholas I Paton, Wolfgang Stöhr, Lars Oddershede, Alejandro Arenas-Pinto, Simon Walker, Mark Sculpher & David T Dunn. (2016) The Protease Inhibitor Monotherapy Versus Ongoing Triple Therapy (PIVOT) trial: a randomised controlled trial of a protease inhibitor monotherapy strategy for long-term management of human immunodeficiency virus infection. Health Technology Assessment 20:21, pages 1-158.
Crossref
Crossref
Nicholas I Paton, Wolfgang Stöhr, Alejandro Arenas-Pinto, Martin Fisher, Ian Williams, Margaret Johnson, Chloe Orkin, Fabian Chen, Vincent Lee, Alan Winston, Mark Gompels, Julie Fox, Karen Scott & David T Dunn. (2015) Protease inhibitor monotherapy for long-term management of HIV infection: a randomised, controlled, open-label, non-inferiority trial. The Lancet HIV 2:10, pages e417-e426.
Crossref
Crossref
. (2015) Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection. New England Journal of Medicine 373:9, pages 795-807.
Crossref
Crossref
Stephen M. Weiss, Jonathan N. Tobin, Maria Lopez, Hannah Simons, Ryan Cook & Deborah L. Jones. (2014) Translating an Evidence-Based Behavioral Intervention for Women Living with HIV into Clinical Practice: The SMART/EST Women’s Program. International Journal of Behavioral Medicine 22:3, pages 415-424.
Crossref
Crossref
Frederick J. Lee, Janaki Amin & Andrew Carr. (2015) Limited reporting of major harms in studies of initial combination antiretroviral therapy. AIDS 29:8, pages 921-929.
Crossref
Crossref
Janaki Amin, Mark A. Boyd, Nagalingeswaran Kumarasamy, Cecilia L. Moore, Marcello H. Losso, Chidi A. Nwizu, Lerato Mohapi, Stephen J. Kerr, Annette H. Sohn, Hedy Teppler, Boris Renjifo, Jean-Michel Molina, Sean Emery & David A. Cooper. (2015) Raltegravir Non-Inferior to Nucleoside Based Regimens in SECOND-LINE Therapy with Lopinavir/Ritonavir over 96 Weeks: A Randomised Open Label Study for the Treatment Of HIV-1 Infection. PLOS ONE 10:2, pages e0118228.
Crossref
Crossref
Mari M. Kitahata, Daniel R. Drozd, Heidi M. Crane, Stephen E. Van Rompaey, Keri N. Althoff, Stephen J. Gange, Marina B. Klein, Gregory M. Lucas, Alison G. Abraham, Vincent Lo Re, Justin McReynolds, William B. Lober, Adell Mendes, Sharada P. Modur, Yuezhou Jing, Elizabeth J. Morton, Margaret A. Griffith, Aimee M. Freeman & Richard D. Moore. (2015) Ascertainment and Verification of End-Stage Renal Disease and End-Stage Liver Disease in the North American AIDS Cohort Collaboration on Research and Design. AIDS Research and Treatment 2015, pages 1-11.
Crossref
Crossref
Annalisa SaracinoGiuseppe BrunoLuigia ScudellerAnna VolpePierluigi CaricatoNicoletta LadisaLaura MonnoGioacchino Angarano. (2014) Chronic Inflammation in a Long-Term Cohort of HIV-Infected Patients According to the Normalization of the CD4:CD8 Ratio. AIDS Research and Human Retroviruses 30:12, pages 1178-1184.
Crossref
Crossref
A. R. Lifson, R. Nelson, R. J. Prineas & D. Duprez. (2014) Re: "Lessons Learned From the Design and Implementation of Myocardial Infarction Adjudication Tailored for HIV Clinical Cohorts". American Journal of Epidemiology 180:4, pages 449-449.
Crossref
Crossref
Nicholas I. Paton, Cissy Kityo, Anne Hoppe, Andrew Reid, Andrew Kambugu, Abbas Lugemwa, Joep J. van Oosterhout, Mary Kiconco, Abraham Siika, Raymond Mwebaze, Mary Abwola, George Abongomera, Aggrey Mweemba, Hillary Alima, Dickens Atwongyeire, Rose Nyirenda, Justine Boles, Jennifer Thompson, Dinah Tumukunde, Ennie Chidziva, Ivan Mambule, Jose R. Arribas, Philippa J. Easterbrook, James Hakim, A. Sarah Walker & Peter Mugyenyi. (2014) Assessment of Second-Line Antiretroviral Regimens for HIV Therapy in Africa. New England Journal of Medicine 371:3, pages 234-247.
Crossref
Crossref
Angie N Pinto, Anthony D Kelleher & David A Cooper. 2005. Encyclopedia of Life Sciences. Encyclopedia of Life Sciences.
Anna D. Nordell, Matthew McKenna, Álvaro H. Borges, Daniel Duprez, Jacqueline Neuhaus & James D. Neaton. (2014) Severity of Cardiovascular Disease Outcomes Among Patients With HIV Is Related to Markers of Inflammation and Coagulation. Journal of the American Heart Association 3:3.
Crossref
Crossref
Christopher J. Miller, Jason V. Baker, Alison M. Bormann, Kristine M. Erlandson, Katherine Huppler Hullsiek, Amy C. Justice, Jacqueline Neuhaus, Roger Paredes, Kathy Petoumenos, Deborah Wentworth, Alan Winston, Julian Wolfson & James D. Neaton. (2014) Adjudicated Morbidity and Mortality Outcomes by Age among Individuals with HIV Infection on Suppressive Antiretroviral Therapy. PLoS ONE 9:4, pages e95061.
Crossref
Crossref
Farrah J. MateenWendy S. PostNed SacktorAlison G. AbrahamJames T. BeckerBryan R. SmithRoger DetelsEileen MartinJohn P. PhairRussell T. Shinohara. (2013) Long-term predictive value of the Framingham Risk Score for Stroke in HIV-positive vs HIV-negative men. Neurology 81:24, pages 2094-2102.
Crossref
Crossref
Annalisa Saracino, Laura Monno, Luigia Scudeller, Giuseppe Bruno, Nicoletta Ladisa, Grazia Punzi, Anna Volpe, Antonella Lagioia & Gioacchino Angarano. (2013) X4 viruses are frequently archived in patients with long-term HIV infection but do not seem to influence the “inflamm-aging” process. BMC Infectious Diseases 13:1.
Crossref
Crossref
Sten H. Vermund, Sarah J. Fidler, Helen Ayles, Nulda Beyers & Richard J. Hayes. (2013) Can Combination Prevention Strategies Reduce HIV Transmission in Generalized Epidemic Settings in Africa? The HPTN 071 (PopART) Study Plan in South Africa and Zambia. JAIDS Journal of Acquired Immune Deficiency Syndromes 63:Supplement 2, pages S221-S227.
Crossref
Crossref
Michael J. VinikoorSonia NapravnikMichelle Floris-MooreSusan WilsonDavid Y. HuangJoseph J. Eron. (2013) Incidence and Clinical Features of Cerebrovascular Disease Among HIV-Infected Adults in the Southeastern United States. AIDS Research and Human Retroviruses 29:7, pages 1068-1074.
Crossref
Crossref
Abdel G Babiker, Sean Emery, Gerd Fätkenheuer, Fred M Gordin, Birgit Grund, Jens D Lundgren, James D Neaton, Sarah L Pett, Andrew Phillips, Giota Touloumi & Michael J Vjechaj. (2012) Considerations in the rationale, design and methods of the Strategic Timing of AntiRetroviral Treatment (START) study. Clinical Trials 10:1_suppl, pages S5-S36.
Crossref
Crossref
. (2013) Ritonavir-boosted lopinavir plus nucleoside or nucleotide reverse transcriptase inhibitors versus ritonavir-boosted lopinavir plus raltegravir for treatment of HIV-1 infection in adults with virological failure of a standard first-line ART regimen (SECOND-LINE): a randomised, open-label, non-inferiority study. The Lancet 381:9883, pages 2091-2099.
Crossref
Crossref
Frederick J. Lee, Janaki Amin, Mark Bloch, Sarah L. Pett, Debbie Marriott & Andrew Carr. (2013) Skeletal Muscle Toxicity Associated With Raltegravir-Based Combination Antiretroviral Therapy in HIV-Infected Adults. JAIDS Journal of Acquired Immune Deficiency Syndromes 62:5, pages 525-533.
Crossref
Crossref
Ronald J. Bosch, Xinyan Zhang & Netanya G. Sandler. (2013) Study design issues in evaluating immune biomarkers. Current Opinion in HIV and AIDS 8:2, pages 147-154.
Crossref
Crossref
Farah Z. Dawood, Faraaz Khan, Mollie P. Roediger, Zhu-Ming Zhang, Shobha Swaminathan, Hartwig Klinker, Jennifer Hoy, Jens D. Lundgren, James D. Neaton & Elsayed Z. Soliman. (2013) Electrocardiographic Spatial QRS-T Angle and Incident Cardiovascular Disease in HIV-Infected Patients (from the Strategies for the Management of Antiretroviral Therapy [SMART] Study). The American Journal of Cardiology 111:1, pages 118-124.
Crossref
Crossref
Amanda Mocroft, Wendy P Bannister, Ole Kirk, Justyna D Kowalska, Peter Reiss, Antonella D'Arminio-Monforte, Jose Gatell, Martin Fisher, Hanna Trocha, Aza Rakhmanova & Jens D Lundgren. (2012) The Clinical Benefits of Antiretroviral Therapy in Severely Immunocompromised HIV-1-Infected Patients with and without Complete Viral Suppression. Antiviral Therapy 17:7, pages 1291-1300.
Crossref
Crossref
Gisele Cristina GosuenGilberto TurcatoJrJrReinaldo SalomaoDavid Salomao LewiRicardo Sobhie Diaz. (2012) Decrease in Lipoatrophy in a Pilot Study Using a Short-Term Treatment Interruption Strategy for 48 Weeks in São Paulo, Brazil. AIDS Research and Human Retroviruses 28:8, pages 747-748.
Crossref
Crossref
Katherine Huppler Hullsiek & Birgit Grund. (2011) Considerations for Endpoint Selection When Designing HIV Clinical Trials. Current Infectious Disease Reports 14:1, pages 110-118.
Crossref
Crossref